Concepedia

Theo Thielemans

TT

4

Publications

496

Citations

4

H-Index

1999

Active since

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

Theo Thielemans is an author at Janssen (Belgium) specializing in medicine, natural sciences, and drug discovery.

Top concepts

MedicineImmunologyBiochemistryData SciencePharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryHigh-throughput ScreeningHiv

Publications per year

1999–2008

4

Publications

4

TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

Koen Andries, Hilde Azijn, Theo Thielemans et al. · Antimicrobial Agents and Chemotherapy · 2004 · 322 citations · Full text

Immunology, Pharmacotherapy, Antiviral Drug +17

Alterations in Mucosal Immunity Identified in the Colon of Patients With Irritable Bowel Syndrome

Jeroen Aerssens, Michael Camilleri, Willem Talloen et al. · Clinical Gastroenterology and Hepatology · 2008 · 124 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Functional Gastrointestinal Disorder +12

CerBeruS: A System Supporting the Sequential Screening Process

Michael Engels, Theo Thielemans, Danny Verbinnen et al. · Journal of Chemical Information and Computer Sciences · 1999 · 29 citations

Engineering, Hit Identification, Sequential Screening Process +22

REALISIS: A Medicinal Chemistry-Oriented Reagent Selection, Library Design, and Profiling Platform

Didier Berthelot, Harry Gijsen, Theo Thielemans et al. · Journal of Chemical Information and Computer Sciences · 2004 · 21 citations

Pharmaceutical Research, Bioorganic Chemistry, Reagent +22

Rows per page

1–4 of 4